Back
EyePoint Pharmaceuticals Stock Price Chart

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
$5.69
Seasonality Move:
9.92%
7 Day Trial
ALL ACCESS PASS
$
7

This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EyePoint Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.19 | Buy |
20-day SMA: | 5.41 | Buy |
50-day SMA: | 6.03 | Sell |
200-day SMA: | 8.18 | Sell |
8-day EMA: | 5.39 | Buy |
20-day EMA: | 5.49 | Buy |
50-day EMA: | 6.09 | Sell |
200-day EMA: | 8.49 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 50.72 | Buy |
Chaikin Money Flow: | 361892 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.92 - 6.26) | Buy |
Bollinger Bands (100): | (5.82 - 8.26) | Sell |
EyePoint Pharmaceuticals Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 5.68 while EYPT 8-day simple moving average is 5.19, which is a Buy signal.
-
The stock price of EYPT is 5.68 while EyePoint Pharmaceuticals 20-day SMA is 5.41, which makes it a Buy.
-
EyePoint Pharmaceuticals 50-day simple moving average is 6.03 while EYPT share price is 5.68, making it a Sell technically.
-
EYPT stock price is 5.68 and EyePoint Pharmaceuticals 200-day simple moving average is 8.18, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a SellThe current EyePoint Pharmaceuticals [EYPT] share price is $5.68. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
390M
Price in USD:
5.68
Share Volume:
557.9K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
21.26
52-Week Low:
3.91
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?The EyePoint Pharmaceuticals stock price is 5.68 USD today.
-
Will EYPT stock go up or go down?EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is EyePoint Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 5.68 while EYPT 8-day exponential moving average is 5.39, which is a Buy signal.
-
The stock price of EYPT is 5.68 while EyePoint Pharmaceuticals 20-day EMA is 5.49, which makes it a Buy.
-
EyePoint Pharmaceuticals 50-day exponential moving average is 6.09 while EYPT share price is 5.68, making it a Sell technically.
-
EYPT stock price is 5.68 and EyePoint Pharmaceuticals 200-day simple moving average is 8.49, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
-
EYPT Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting EyePoint Pharmaceuticals is a Sell
-
EyePoint Pharmaceuticals Relative Strength Index (RSI) is 50.72, which suggest EyePoint Pharmaceuticals is overbought
-
The Bollinger Bands (25) for EyePoint Pharmaceuticals is (4.92 - 6.26), which suggest EyePoint Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for EyePoint Pharmaceuticals is (5.82 - 8.26), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.